Assialioui, A.; DomÃnguez, R.; Ferrer, I.; Andrés-Benito, P.; Povedano, M.
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022, 23, 11063.
https://doi.org/10.3390/ijms231911063
AMA Style
Assialioui A, DomÃnguez R, Ferrer I, Andrés-Benito P, Povedano M.
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 2022; 23(19):11063.
https://doi.org/10.3390/ijms231911063
Chicago/Turabian Style
Assialioui, Abdelilah, Raúl DomÃnguez, Isidro Ferrer, Pol Andrés-Benito, and Mónica Povedano.
2022. "Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis" International Journal of Molecular Sciences 23, no. 19: 11063.
https://doi.org/10.3390/ijms231911063
APA Style
Assialioui, A., DomÃnguez, R., Ferrer, I., Andrés-Benito, P., & Povedano, M.
(2022). Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 23(19), 11063.
https://doi.org/10.3390/ijms231911063